Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,450 | 4 | 78.6% |
| Food and Beverage | $1,155 | 55 | 10.7% |
| Travel and Lodging | $1,064 | 8 | 9.9% |
| Education | $75.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MDD US Operations, LLC | $9,931 | 16 | $0 (2021) |
| ABBVIE INC. | $620.38 | 46 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $98.72 | 2 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $60.49 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $18.99 | 1 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $14.90 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.47 | 3 | Supernus Pharmaceuticals, Inc. ($45.50) |
| 2023 | $351.40 | 20 | ABBVIE INC. ($242.51) |
| 2022 | $161.02 | 17 | ABBVIE INC. ($161.02) |
| 2021 | $10,146 | 28 | MDD US Operations, LLC ($9,931) |
All Payment Transactions
68 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $45.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/13/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Neuroscience | ||||||
| 12/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.89 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/29/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Neuropsychiatry | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $75.00 | General |
| Category: Neuroscience | ||||||
| 04/04/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.69 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $83.43 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 96 | 218 | $19,100 | $9,165 |
| 2022 | 4 | 169 | 320 | $27,757 | $12,341 |
| 2021 | 4 | 150 | 235 | $21,022 | $14,681 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 165 | $12,375 | $5,704 | 46.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 18 | 18 | $2,525 | $1,763 | 69.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 35 | $4,200 | $1,698 | 40.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 145 | $10,896 | $5,001 | 45.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 48 | 115 | $9,200 | $3,378 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 43 | $5,240 | $2,244 | 42.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 17 | 17 | $2,421 | $1,718 | 70.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 64 | 122 | $9,760 | $6,685 | 68.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 44 | $5,052 | $3,476 | 68.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 53 | $3,985 | $2,784 | 69.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 15 | 16 | $2,225 | $1,736 | 78.0% |
About Mallori Levengood
Mallori Levengood is a Psychiatric/Mental Health healthcare provider based in Pine Bluff, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2021. The National Provider Identifier (NPI) number assigned to this provider is 1871185066.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mallori Levengood has received a total of $10,744 in payments from pharmaceutical and medical device companies, with $85.47 received in 2024. These payments were reported across 68 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,450).
As a Medicare-enrolled provider, Levengood has provided services to 415 Medicare beneficiaries, totaling 773 services with total Medicare billing of $36,187. Data is available for 3 years (2021–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Pine Bluff, AR
- Active Since 02/09/2021
- Last Updated 02/09/2021
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1871185066
Products in Payments
- APOKYN (Drug) $9,931
- VRAYLAR (Drug) $620.38
- INVEGA SUSTENNA (Drug) $98.72
- Qelbree (Drug) $45.50
- Auvelity (Drug) $18.99
- QELBREE (Drug) $14.99
- INGREZZA (Drug) $14.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Pine Bluff
Diane Boyd, Apn, APN
Psychiatric/Mental Health — Payments: $2,083
Dr. Ashley James, Dnp, Aprn, DNP, APRN
Psychiatric/Mental Health — Payments: $1,825
Devon Deden, Aprn-Cnp, APRN-CNP
Psychiatric/Mental Health — Payments: $211.83
Toni Thomas, Lpn, LPN
Psychiatric/Mental Health — Payments: $79.80
Michele Reynolds, Anp, ANP
Psychiatric/Mental Health — Payments: $23.22
Ms. Sherry Raber, Rn, RN
Psychiatric/Mental Health